Showing results (1-10 of 45) with videos related to
Sort By:
Pageof 5
Journal of Clinical Lipidology|September 27, 2012
Hospital use and medical care costs up to 5 years after triglyceride lowering among patients with severe hypertriglyceridemiaGregory A Nichols, Bhakti Arondekar, Terry A JacobsonThe American Journal of Managed Care|December 11, 2008
Complications of dysglycemia and medical costs associated with nondiabetic hyperglycemiaGregory A Nichols, Bhakti Arondekar, William H HermanMedical Care|April 5, 2008
Medical care costs one year after identification of hyperglycemia below the threshold for diabetesGregory A Nichols, Bhakti Arondekar, William H HermanThe American Journal of Cardiology|January 8, 2011
Patient characteristics and medical care costs associated with hypertriglyceridemiaGregory A Nichols, Bhakti Arondekar, Louis P GarrisonThe Annals of Pharmacotherapy|April 8, 2010
Adherence to a fixed-dose combination of rosiglitazone/glimepiride in subjects switching from monotherapy or dual therapy with a thiazolidinedione and/or a sulfonylureaSarah Thayer, Bhakti Arondekar, Carolyn Harley, et al.Diabetes Care|December 12, 2007
Diabetes Risk Calculator: a simple tool for detecting undiagnosed diabetes and pre-diabetesKenneth E Heikes, David M Eddy, Bhakti Arondekar, et al.Clinical Therapeutics|March 18, 2008
A retrospective analysis of the fasting plasma glucose and glycosylated hemoglobin and pharmacotherapy change patterns among type 2 diabetes mellitus patientsJaime Davidson, Carol Koro, Bhakti Arondekar, et al.Human Vaccines & Immunotherapeutics|November 27, 2014
Burden of vaccine-preventable disease in adult Medicaid and commercially insured populations: analysis of claims-based databases, 2006–2010Girishanthy Krishnarajah, Charlotte Carroll, Julie Priest, et al.Clinicoeconomics and Outcomes Research : CEOR|January 26, 2019
Health-related quality of life in acute myeloid leukemia patients not eligible for intensive chemotherapy: results of a systematic literature reviewAnna Forsythe, Christina S Kwon, Timothy Bell, et al.Journal of Managed Care & Specialty Pharmacy|October 29, 2021
Payer perceptions on the use of economic models in oncology decision makingJoseph Biskupiak, Gary Oderda, Diana Brixner, et al.Pageof 5